Modulatory_JJ
effects_NNS
of_IN
glucocorticoids_NNS
and_CC
catecholamines_NNS
on_IN
human_JJ
interleukin-12_NN
and_CC
interleukin-10_NN
production_NN
:_:
clinical_JJ
implications_NNS
._.

Interleukin-12_NN
-LRB-_-LRB-
IL-12_NN
-RRB-_-RRB-
is_VBZ
a_DT
key_JJ
inducer_NN
of_IN
differentiation_NN
of_IN
uncommitted_JJ
T_NN
helper_NN
-LRB-_-LRB-
TH_NN
-RRB-_-RRB-
cells_NNS
toward_IN
the_DT
TH1_NN
phenotype_NN
,_,
which_WDT
regulates_VBZ
cellular_JJ
immunity_NN
,_,
whereas_IN
IL-10_NN
inhibits_VBZ
TH1_NN
functions_NNS
and_CC
potentiates_VBZ
TH2-regulated_JJ
responses_NNS
-LRB-_-LRB-
i.e._FW
,_,
humoral_JJ
immunity_NN
-RRB-_-RRB-
._.

To_TO
examine_VB
the_DT
potential_JJ
effects_NNS
of_IN
stress_NN
on_IN
TH1\/TH2_NN
balance_NN
,_,
we_PRP
studied_VBD
the_DT
ability_NN
of_IN
three_CD
prototype_NN
stress_NN
hormones_NNS
-_:
dexamethasone_NN
-LRB-_-LRB-
a_DT
synthetic_JJ
glucocorticoid_NN
-RRB-_-RRB-
and_CC
the_DT
catecholamines_JJ
norepinephrine_NN
and_CC
epinephrine_NN
-_:
to_TO
alter_VB
the_DT
production_NN
of_IN
IL-12_NN
-LRB-_-LRB-
p70_NN
-RRB-_-RRB-
and_CC
IL-10_NN
induced_VBN
by_IN
bacterial_JJ
lipopolysaccharide_NN
-LRB-_-LRB-
LPS_NN
-RRB-_-RRB-
in_IN
human_JJ
whole_JJ
blood_NN
._.

Dexamethasone_NN
inhibited_VBD
LPS-induced_JJ
bioactive_JJ
IL-12_NN
production_NN
in_IN
a_DT
dose-dependent_JJ
fashion_NN
and_CC
at_IN
physiologically_RB
relevant_JJ
concentrations_NNS
;_:
it_PRP
had_VBD
no_DT
effect_NN
on_IN
IL-10_NN
secretion_NN
._.

The_DT
glucocorticoid-induced_JJ
reduction_NN
of_IN
IL-12_NN
production_NN
was_VBD
antagonized_VBN
by_IN
RU_NN
486_CD
,_,
a_DT
glucocorticoid-receptor_JJ
antagonist_NN
,_,
suggesting_VBG
that_IN
it_PRP
was_VBD
mediated_VBN
by_IN
the_DT
glucocorticoid_NN
receptor_NN
._.

Norepinephrine_NN
and_CC
epinephrine_NN
also_RB
suppressed_VBD
IL-12_NN
production_NN
in_IN
a_DT
dose-dependent_JJ
fashion_NN
and_CC
at_IN
physiological_JJ
concentrations_NNS
;_:
both_CC
catecholamines_NNS
,_,
however_RB
,_,
dose-dependently_RB
increased_VBD
the_DT
production_NN
of_IN
IL-10_NN
._.

The_DT
effects_NNS
of_IN
either_CC
catecholamine_NN
on_IN
IL-12_NN
or_CC
IL-10_NN
secretion_NN
were_VBD
blocked_VBN
completely_RB
by_IN
propranolol_NN
,_,
a_DT
beta-adrenoreceptor_JJ
antagonist_NN
,_,
indicating_VBG
that_IN
they_PRP
were_VBD
mediated_VBN
by_IN
the_DT
beta-adrenergic_JJ
receptor_NN
._.

These_DT
findings_NNS
suggest_VBP
that_IN
the_DT
central_JJ
nervous_JJ
system_NN
may_MD
regulate_VB
IL-12_NN
and_CC
IL-10_NN
secretion_NN
and_CC
,_,
hence_RB
,_,
TH1\/TH2_NN
balance_NN
via_IN
the_DT
peripheral_JJ
end-effectors_NNS
of_IN
the_DT
stress_NN
system_NN
._.

Thus_RB
,_,
stress_NN
may_MD
cause_VB
a_DT
selective_JJ
suppression_NN
of_IN
TH1_NN
functions_NNS
and_CC
a_DT
shift_NN
toward_IN
a_DT
TH2_NN
cytokine_NN
pattern_NN
rather_RB
than_IN
generalized_VBN
TH_NN
suppression_NN
._.

The_DT
TH1-to-TH2_JJ
shift_NN
may_MD
be_VB
responsible_JJ
for_IN
the_DT
stress-induced_JJ
susceptibility_NN
of_IN
the_DT
organism_NN
to_TO
certain_JJ
infections_NNS
._.

Through_IN
the_DT
same_JJ
or_CC
a_DT
reciprocal_JJ
mechanism_NN
,_,
states_NNS
associated_VBN
with_IN
chronic_JJ
hyperactivity_NN
or_CC
hypoactivity_NN
of_IN
the_DT
stress_NN
system_NN
might_MD
influence_VB
the_DT
susceptibility_NN
of_IN
an_DT
individual_NN
to_TO
certain_JJ
autoimmune_JJ
,_,
allergic_JJ
,_,
infectious_JJ
,_,
or_CC
neoplastic_JJ
diseases_NNS
._.

